Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.

Also called NCT05102019

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 380 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05102019
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05102019. Randomized; double masking; primary purpose treatment. Start 2022-01-04 (actual); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Acronym
COSIRA-II
Condition
Refractory Angina
Intervention (Device)
Arm 1: treatment with Shockwave Reducer
Intervention (Other)
Arm 2 (control): Implantation procedure with no device implanted
Intervention (Device)
Arm 3 (unblinded, non-randomized): Single arm registry
Lead sponsor
Shockwave Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05102019
Content hash
b9cf13c650a815a4ef6f985fc55c7578b610067d940b8b0b4f0880be6bda61b1